Inflammasomes are multi-protein complexes integrating pathogen-triggered signaling leading to the generation of proinflammatory cytokines including interleukin-18 (IL-18). Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections are associated with elevated IL-18, suggesting inflammasome activation. However, there is marked person-to-person variation in the inflammasome response to HCV and HIV. We hypothesized that host genetics may explain this variation. To test this, we analyzed the associations of plasma IL-18 levels and polymorphisms in 10 genes in the inflammasome cascade. About 1538 participants with active HIV and/or HCV infection in three ancestry groups are included. Samples were genotyped using the Illumina Omni 1-quad and Omni 2.5 arrays. Linear regression analyses were performed to test the association of variants with log IL-18 including HCV and HIV infection status, and HIV RNA in each ancestry group and then meta-analyzed. Eleven highly correlated single-nucleotide polymorphisms (r 2 = 0.98-1) in the IL-18-BCO2 region were significantly associated with log IL-18; each T allele of rs80011693 confers a decrease of 0.06 log pg ml − 1 of IL-18 after adjusting for covariates (rs80011693; rs111311302 β = − 0.06, P-value = 2.7 × 10 − 4 ). In conclusion, genetic variation in IL-18 is associated with IL-18 production in response to HIV and HCV infection, and may explain variability in the inflammatory outcomes of chronic viral infections.
INTRODUCTION
Inflammasomes are multi-protein cytosolic complexes that integrate several pathogen-triggered signaling cascades, ultimately leading to caspase 1 activation and the generation of proinflammatory cytokines including interleukin (IL)-18 and IL-1 beta (IL-1β). 1, 2 Although there are inflammasome-dependent and -independent means to induce mature IL-1β production, [3] [4] [5] to date, inflammasome activation has been the only mechanism described to convert pro-IL-18 to mature IL-18. 6 Thus, higher levels of IL-18 are indicative of inflammasome activation. Both hepatitis C virus (HCV) and human immunodeficiency virus (HIV) are known to activate a specific inflammasome, the NOD-like receptor (NLR) family, pyrin domain containing 3 (NLRP3) inflammasome, as measured by increases in IL-18. For example, plasma IL-18 levels increase sharply during the acute phase of HCV infection, remain elevated in those with persistent infection, and return to the preinfection level with spontaneous resolution of HCV. 7 Similarly, levels are elevated in patients with chronic hepatitis and cirrhosis, and reduced after the infection is resolved either spontaneously 8 or after antiviral treatment. 9 IL-18 levels are also elevated in HIV infection, an effect that is partially reversed by antiretroviral therapy. 10, 11 Genetic determinants of IL-18 levels have been demonstrated in cohorts of individuals from different age groups without chronic viral infections. [12] [13] [14] Several independent loci have been correlated with serum IL-18 levels in multiple genome-wide association studies including the IL-18 and beta-carotene oxygenase 2 (IL-18-BCO2) gene region of chromosome 11, the NLR family, and caspase activation and recruitment domains (CARD) domain containing 4 (NLRC4) gene on chromosome 2.
12-14 Associations of serum IL-18 levels and single-nucleotide polymorphisms (SNPs) in the IL-18 gene were replicated in several populations of European ancestry (EA) with different demographic characteristics including women with no history of chronic illness, 14 women with and without Type 2 diabetes, 14 individuals with and without premature coronary heart disease 15 and older adults. 12 Strong genetic effects in cis location have been suggested, however the biological mechanisms underlying the genetic associations are unknown.
Compared to what is observed in studies of persons without chronic viral infection, there is a wider range of IL-18 elevation observed in persons with chronic viral infection that cannot be explained by age, race or gender. 2, 7, 16, 17 This suggests that host 1 School of Medicine, Johns Hopkins University, Baltimore, MD, USA; genetic differences may partially explain variation in IL-18 response to viral infection. To investigate this hypothesis, we measured IL-18 levels in individuals with well-characterized chronic and active HIV viremia and/or HCV viremia, and evaluated the association of SNPs in 10 key genes in the viral-NLPR3 inflammasome activation pathway.
RESULTS

Participants
Demographic characteristics of the analyzed individuals are presented in Table 1 . HIV-infected individuals were not under antiretroviral therapy. All individuals had their ancestry defined by principal component analysis using genetic variants. There were 386 individuals of EA, 796 of African ancestry (AA) and 356 of mixed or other ancestry. Age (P-value = 0.94), ancestry (P-value = 0.09) and sex (P-value = 0.13) were not associated with log IL-18.
Log plasma IL-18 by infection status Log IL-18 was significantly higher in 450 persons with both HIV and HCV infections (mean = 2.76 log pg ml − 1 , s.d. = 0.27 log pg ml − 1 ) than in the 668 HIV-monoinfected (mean = 2.61 log pg ml − 1 , s.d. = 0.30 log pg ml
) and the 420 HCV-monoinfected participants (mean = 2.50 log pg ml − 1 , s.d. = 0.30 log pg ml − 1 ), P-value = 2.2 x 10 − 16 for the three-group comparison, Figure 1 . Similar results were observed for each ancestry group independently (Supplementary Figure 1) . The multivariable analysis after adjusting for the principal components demonstrates that the level of HIV RNA in plasma is also determinant of IL-18 levels in all individuals (Table 2) as well as in each ancestry group (Supplementary Table 1 ). Specifically, there was a progressive increase in log IL-18 as HIV RNA increases from low, to moderate and high levels in both the HIV-monoinfected and HIV-HCV-coinfected groups compared to the HCV-monoinfected individuals. However, HIV/HCV infection, HIV RNA and principal components only accounted for 14% of the variance in IL-18 levels.
Genetic association analysis From 10 genes spanning a total of~519 kb of DNA (Supplementary Table 2 ), we evaluated 721 genetic variants for EA, 1307 for AA and 1170 for mixed or other ancestry. We found an association of IL-18 levels and variants in the IL-18-BCO2 region in chromosome 11. The SNPs significantly associated with IL-18 levels after adjusting for the principal components and the HIV and HCV categories are shown in Figure 2 . Table 3 displays their allelic frequency, effect size estimates and the annotation of the function and expression quantitative trait loci information described in public databases (https://genome.ucsc.edu/index. of IL-18 after adjusting for HIV-HCV infection, HIV RNA levels and ancestry (Table 3 and Supplementary Table 3 ). The direction of the effect of the associated variants is the same across ancestry groups. They were in high linkage disequilibrium (LD) in the three ancestry groups (r 2 = 0.98-1). After conditioning on each of the associated SNPs, the remaining SNPs in the IL-18-BCO2 were not significant ( Supplementary Figure 3) , highlighting the strong LD across this region. Associations between log IL-18 and polymorphisms in IL-1β, ASCC1, NLRP3, NFKB1, NFKB2, CASP1, TLR7, TLR8 and MYD88 did not reach statistical significance after correcting for multiple tests.
DISCUSSION
This investigation extends previous associations of genetic factors with IL-18 plasma levels by demonstrating that the variants in the IL-18-BCO2 region are important determinants of plasma IL-18 levels in the presence of a chronic viral infection. Prior studies demonstrated the importance of this region in persons without an ongoing infection. [12] [13] [14] Compared to the SNPs, the greater magnitude of the effects (β regression coefficient) associated with HIV monoinfection and HIV-HCV co-infection confirm the dominant role of viral infections explaining person-to-person differences in IL-18 levels. 7, 8 However, these dominant viral associations only accounted for a low percentage of the variance in IL-18 levels, suggesting that there are other unmeasured factors responsible for the person-to-person differences in IL-18 levels in each infection group. Our findings suggest that this genetic region has an important role in determining plasma IL-18 levels. It is also notable that in our multivariable model, no other non-genetic factor was as important, including ancestry.
The results of this and previous studies indicate a consistent locus effect in the IL-18 region represented by a SNP to SNP replication across studies. The association of genetic variants in IL-18 on plasma IL-18 levels was studied in older European adults included in the Cardiovascular Health Study (CHS) 12 and European individuals in the In-CHIANTI study. 13 They detected an association of IL-18 levels with rs1834481 and rs5744256, two intronic SNPs Genetics of plasma IL-18 in HCV/HIV infections C Vergara et al that were also significantly associated with IL-18 levels in our study. Likewise, rs1834481 was associated with IL-18 levels in a genome-wide association study of 1523 women of EA from the Nurses' Health Study (NHS) and 435 from the Women's Genome Health Study (WGHS). 14 Moreover, rs5744256 and rs2043055 were previously associated with IL-18 levels in candidate gene studies in healthy individuals and in individuals with premature cardiovascular disease, respectively. 15, 18, 19 We looked at the publicly available RNA expression data 20, 21 to investigate the relationship of any of the associated SNPs or other SNPs with expression of IL-18 levels in diverse tissues. Of the 11 variants described in this study, 10 have been described as expression quantitative trait locis in tissues such as lung, pancreas and skin. 21 Other SNPs not included in the present analysis, such as rs7020926, rs7030024, rs13283237, rs7851038 and rs944363, are described as related to IL-18 expression levels in circulating monocytes analyzed in 1490 unrelated European individuals, 22 but no direct biological mechanism has yet been demonstrated.
BCO2 variants have also been reported as associated with serum IL-18 level. In the CHS and In-CHIANTI cohorts, rs2250417 was significantly associated with IL-18 protein levels 13 in each individual cohort as well as the meta-analysis (P-value = 1.9 × 10 − 32 ). Similarly, He et al.
14 describes three different variants (rs2115763, rs12420140 and rs4935984) in this gene as associated with IL-18 levels in the NHS-WGHS. The associated variants in the BCO2 gene in the different studies (rs2250417, rs10891343, rs2115763, rs12420140 and rs4935984) are in high LD (D' = 0.99-1) with the associated SNPs in our study in populations of African, European, Asian descent, as well as admixed populations in The 1000 Genomes project (http://www.1000genomes.org/). However, as they were not genotyped or imputed in this study, we cannot rule out their role on IL-18 levels in this analysis.
Even though there is a clear effect of genetic determinants in plasma IL-18 levels, much of the inter-individual differences remain unexplained. Circulating levels and biological activity depends on the level of production of IL-18, its natural inhibitory protein IL-18BP (IL-18 binding protein) as well as the surface expression of IL-18 receptors (IL-18R) on responding cells. 23 Thus, variation in the levels of IL-18 might be determined by polymorphisms regulating the expression of these genes or as yet unidentified genes that encode for the proteins that interact with IL-18. Environmental factors such as bacterial and other viral infections stimulating the innate and acquired immune responses concurrently with HCV and HIV may also affect IL-18 levels. However, IL-18 levels have been shown to be stable both before (low levels) and in the chronic phase of (high levels) HCV infection, suggesting that exposure to other infections may play a lesser role than HCV in regulating total levels. In addition, chronic or acute conditions activating the inflammasome, and epigenetic mechanisms regulating the expression of the IL-18 protein are among other potential modulators of IL-18 variation.
On the other hand, pro-IL-18 is constitutively expressed, 24,25 its expression increases from baseline levels after the signal 1 and inflammasome assembly results in maturation of IL-18, and its release into extracellular space. 26, 27 We hypothesize that baseline constitutive expression levels of pro-IL-18 are regulated by genetic determinants represented by the associated variants and, that caspase 1 activation converts pro-IL-18 to mature IL-18 with greater production of mature IL-18 when pro-IL-18 levels are higher. Thus, the higher baseline pro-IL-18 in the individuals with the risk alleles results in higher levels of mature IL-18 production upon inflammasome activation. This would be expected if caspase 1 enzymatic activity is not limiting upon activation and is consistent with the literature on IL-18 regulation. 24, 28 Our perspective is also influenced by the observation we make in humans infected with HIV or HCV in whom there is a marked increase in plasma total IL-18 that remains elevated for decades or until with HCV, the infection is eliminated, at which time it comes back to baseline. 7 Those increases in total plasma IL-18 level following HCV or HIV infection vary markedly from person to person, persist for decades, and undoubtedly are multifactorial but yet poorly understood. Thus, we aimed to study the full range of genes that might contribute, even if the gene doesn't fit the current models of inflammasome activation. We established that there is a genetic basis for differences in plasma IL-18 levels in persons with chronic viral infection that warrants investigation of the molecular mechanisms underlying those observations.
MATERIALS AND METHODS
Study participants
A total of 1538 individuals were selected from five different study cohorts: the AIDS Link to the Intravenous Experience (ALIVE), 29 Baltimore Before and After Acute Study of Hepatitis (BBAASH), 30 Boston Area HCV Study Transmission, Immunity, Outcomes Network (BAHSTION), 31 Correlates of Resolved Versus Low-Level Viremic Hepatitis C Infection in Blood Donors (REVELL Study) 32 and Women's Interagency HIV Study (WIHS), 33 as previously described. 34 The inclusion criteria were the availability of genome-wide genotyping data and evidence of active HCV and/or HIV infection as determined by presence of both antibodies and detectable RNA levels for more than 6 months prior to the date of IL-18 testing, as described previously. 
IL-18 plasma levels
Mature IL-18 was measured in plasma from reposited specimens using enzyme-linked immunosorbent assay (MBL International, Woburn, MA, USA) on a sample taken prior to antiretroviral therapy in the HIV-infected participants. The assay was performed per the manufacturer's recommendations using 50 μl of plasma. Data were acquired using a SpectraMax M5 (Molecular Devices, Sunnyvale, CA, USA). The sensitivity of this assay is 12.5 pg ml − 1 and the average intra-assay coefficient of variation is 7.25%.
Statistical analysis
Plasma IL-18 levels, log-transformed for approximate normalization were the primary outcomes. HIV and HCV infection status, HIV RNA levels, genetic ancestry, gender and age were each included in the statistical model of linear regression to determine their effect on log IL-18. HCV and HIV infection status, and HIV RNA variables were modeled as a unique categorical variable that we refer to as 'HIV-HCV infection, HIV RNA'. This variable groups the individuals into seven categories: HCV monoinfected, HIV monoinfected with low (400-10 K copies per ml), moderate (10 -50 K copies per ml) and high HIV RNA levels (450 K copies per ml), and coinfected with low, moderate and high HIV RNA levels. Analysis of variance was used to compare log IL-18 levels between HCV-monoinfected, HIVmonoinfected and HIV-HCV co-infected individuals with all individuals and by genetic ancestry.
Genetic ancestry analysis
Genetic ancestry was determined by principal components based on 10 340 unlinked SNPs across the genome using the smartpca program from the software package eigenstrat. 35 Principal components analysis is used to summarize the background genetic variation of populations into a few variables that represent ancestral origin. Three distinct ancestry groups emerged including EA, AA and mixed or other ancestry, which likely includes Hispanic and Asian ancestry (Supplementary Figure 2) .
Genotyping and imputation
The SNP genotyping data were obtained from a larger genome-wide association study 34 using the Illumina Human Omni-Quad array for samples from the ALIVE, BBAASH, BAHSTION and REVELL study groups and using the Illumina Omni 2.5 array for the WIHS group. The selected SNPs are part of the NLRP3 inflammasome pathway and include the genes and 10 kilobases upstream and downstream of each gene. The pathway genes included were IL-18, IL-1β, activating signal cointegrator 1 complex Genetics of plasma IL-18 in HCV/HIV infections C Vergara et al subunit 1 (ASCC1), NLR family, pyrin domain containing 3 (NLRP3); nuclear factor kappa B subunit 1 (NF-κβ1), nuclear factor kappa B subunit 2 (NF-κβ2), caspase (CASP1), toll-like receptor 7 (TLR7), toll-like receptor 8 (TLR8), myeloid differentiation primary response 88 (MYD88) and BCO2. Genomic coordinates were based on the Human GRCh37/hg19 assembly (Supplementary Table 2 ). Genomic imputation was performed for each chromosomal region using IMPUTE2. 36 The reference panel consisted of 2504 individuals representing four continental populations (Africa, Americas, Asia and Europe) as part of the 1000 Genomes Project. 37 Each genetic platform was individually imputed using all individuals and the imputed data sets were merged based on genetic ancestry groups using the software Plink version 1.90 beta (https://www.cog-genomics.org/ plink2). Only variants with an information score 40.3 and a genotyping probability 490% were included in the analysis. 38 Standard quality control measures were employed pre and post imputation (excluding variants with minor allele frequency o0.01, missing call rate ⩾ 1%, Hardy-Weinberg equilibrium test P-value o 1 × 10 − 5). Genotyped and high-quality imputed variants that were common to both platforms were included in the regression analysis.
Genetic association analysis
Plink was used to analyze linear regression models adjusting for five principal components and HIV-HCV infection, HIV RNA. SNPs were modeled under an additive model in which genotypes are represented as 0, 1, 2 copies of the minor allele. Ancestry groups were tested separately and the results were meta-analyzed by combining ancestry-specific β (regression coefficient) estimates using a fixed effects inverse variance model 39 implemented in META. 40 LD (r 2 ) was determined in each of the genetic regions by the ancestral group. This informed a modified Bonferroni correction using the effective number of independent SNPs (n = 103 SNPs for AA, n = 38 for EA and n = 57 for mixed or other ancestry, n = 197 total variants). Twenty-five of the 197 SNPs were common between at least two ancestry groups, and the remaining were unique. A modified Bonferroni corrected P-value o2.9 × 10 − 4 was considered statistically significant.
